This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Andreas Kuhn, PhD
Senior Vice President, RNA Biochemistry & Manufacturing at BioNTech RNA Pharmaceuticals GmbH

Profile

Andreas Kuhn has worked in the field of RNA biochemistry and molecular biology for more than thirty years. His work on RNA-based immunotherapies began in 2007 in the academic group of Ugur Sahin at the University Clinic Mainz, and Andreas joined BioNTech RNA Pharmaceuticals GmbH shortly after its founding in 2008. In his current role as Senior Vice President RNA Biochemistry & Manufacturing the main focus is expanding proprietary technologies to increase the efficacy of RNA-based therapies and to optimize GMP-compatible manufacturing processes for RNA. He has co-authored numerous publications and patents ranging from basic research on RNA to its application as a diagnostic and therapeutic agent.

Agenda Sessions

  • Keynote Introduction by Session Chair and KEYNOTE PRESENTATION with Live Q&A – Usage of an mRNA Platform Technology for “Light Speed” Development of a Vaccine against SARS-CoV-2”

    10:15
  • SESSION NAME: Vaccine and Therapeutic Development for COVID-19 SESSION CHAIRS & SPEAKERS BELOW:

    On Demand
  • Usage of an mRNA Platform Technology for “Light Speed” Development of a Vaccine against SARS-CoV-2”

    On Demand
  • Vaccine and Therapeutic Development for COVID-19

    11:15